The Quintessence of Basic and Clinical Research and Scientific Publishing | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Fortunato Senatore
B01=Gowraganahalli Jagadeesh
B01=Pitchai Balakumar
Category1=Non-Fiction
Category=MBDC
Category=MBGR
Category=TCB
COP=Singapore
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€100 and above
PS=Active
softlaunch

The Quintessence of Basic and Clinical Research and Scientific Publishing

English

The book, intended for biomedical researchers, attempts to foster a comprehensive understanding of the elements that impact scientific research, such as clinical trial design, communication, and publication methods.

It introduces the process of idea generation and creative/critical thinking, leading to the development of key concepts that coalesce into theoretical constructs and working hypotheses. The book systematically delineates research phases associated with a bench-to-bedside translational approach, providing the full depth and breadth of drug discovery and development: design, synthesis, and optimization of drug candidates interacting with targets linked to diseases, as well as clinical trial design to acquire substantial evidence of efficacy and safety for candidate drugs in the target patient population.

New and evolving topics such as artificial intelligence, machine and deep learning, drug repurposing approaches, and bioinformatics, are incorporated intothe text as these features are becoming integrated into drug research and development. Additionally, it covers publication strategies, including literature search, manuscript preparation, data presentation, relevant discussion, editorial processes, elements of peer review, and bibliometrics. Finally, the book addresses grantsmanship, key strategies for building effective networks, mentorships, maintaining research integrity, and forging career advancement opportunities, including entrepreneurship.

See more
Current price €116.84
Original price €122.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Fortunato SenatoreB01=Gowraganahalli JagadeeshB01=Pitchai BalakumarCategory1=Non-FictionCategory=MBDCCategory=MBGRCategory=TCBCOP=SingaporeDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€100 and abovePS=Activesoftlaunch

Will deliver when available. Publication date 24 Oct 2024

Product Details
  • Dimensions: 178 x 254mm
  • Publication Date: 03 Oct 2024
  • Publisher: Springer Verlag Singapore
  • Publication City/Country: Singapore
  • Language: English
  • ISBN13: 9789819912865

About

Gowraganahalli Jagadeesh Ph.D. has worked for more than three decades for the US Food and Drug Administration as a Senior Expert Pharmacologist in the Office of Cardiology Hematology Endocrinology and Nephrology at the Center for Drug Evaluation and Research. He was an Adjunct Scientist at the NIH Bethesda while working at the FDA. He had also taught at Banaras Hindu University Varanasi India and was a Canadian Heart Foundation Fellow and NIH staff scientist (at Northeastern University Boston). Dr. Jagadeesh received B. Pharm MSc and Ph.D. degrees from RGUS-Bengaluru All-India Institute of Medical Sciences-Delhi and BHU respectively. He is currently a Distinguished Visiting Professor at College of Pharmaceutical Sciences Dayananda Sagar University Bengaluru; and a visiting professor at College of Pharmacy Adichunchanagiri University BG Nagara Karnataka; and College of Pharmaceutical Sciences Manipal Academy of Higher Education (Deemed-to-be University) Manipal India. More than 60 scientific papers including book chapters have been authored by him and he has edited three books as well.   Pitchai Balakumar M.Pharm. Ph.D. is working as Professor & Director Centre for Scholarly Scientific Training and Publishing The Office of Research and Development Periyar Maniammai Institute of Science & Technology (Deemed-to-be University) Vallam Tamil Nadu India. Previously he was a Professor of Pharmacology at King Khalid University Saudi Arabia and Senior Associate Professor and Head of Pharmacology Unit at the Faculty of Pharmacy AIMST University Malaysia. He was the Visiting Scientist at the University of Montreal Canada in 2009. Prof. Balakumars name has been featured for the third consecutive time (since 2020) among the World Ranking Top 2% Scientists in the Field: Pharmacology & Pharmacy based on a study done by Stanford University scientists. He obtained M.Pharm and Ph.D. degrees in Pharmacology specialized in Cardiovascular Pharmacology from Punjabi University-Patiala Punjab India. He has two decades of teaching research and editorial experience in the field of Cardiovascular-Renal Sciences and trained several graduates in India and abroad. He has published around 125 scientific papers (over 5350 citations with h-index 40) and received several awards and honors for excellence in overall academic and research performance. Along with two senior scientists from the US FDA Prof. Balakumar edited a reference book titled Pathophysiology and Pharmacotherapy of Cardiovascular Disease published by Springer in 2015. He also edited a number of focused Special Issues in cardiovascular sciences. Prof. Balakumar is a 'Consulting Editor' at Pharmacological Research-Elsevier.   Fortunato Fred Senatore MD PhD FACC received his bachelor degree in biochemistry and master degree in biomedical engineering from Columbia University and Ph.D. in chemicalengineering from Rutgers University. He served as an assistant professor of chemical engineering at Texas Tech University and focused on artificial organ research and biocompatible prostheses. He attended medical school at the Texas Tech University School of Medicine during his tenure at the Texas Tech University School of Engineering. He trained in Internal Medicine at the Mayo Clinic and Cardiology at Harvard University-Massachusetts General Hospital. He served in the pharmaceutical industry with increasing levels of responsibility for 17 years where he conducted and supervised clinical research in cardiovascular disease renal disease and endocrinology. He subsequently joined the FDA in the Division of Cardiology and Nephrology and has been serving as Medical Officer since 2012. For the past four years he has been serving as Lead Physician.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept